Matches in Wikidata for { <http://www.wikidata.org/entity/Q99560587> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q99560587 description "article scientifique publié en 2020" @default.
- Q99560587 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99560587 description "scientific article published on 17 September 2020" @default.
- Q99560587 description "wetenschappelijk artikel" @default.
- Q99560587 description "наукова стаття, опублікована 17 вересня 2020" @default.
- Q99560587 name "Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion" @default.
- Q99560587 name "Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion" @default.
- Q99560587 type Item @default.
- Q99560587 label "Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion" @default.
- Q99560587 label "Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion" @default.
- Q99560587 prefLabel "Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion" @default.
- Q99560587 prefLabel "Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion" @default.
- Q99560587 P1433 Q99560587-3A0DF471-DB31-4B72-9BB6-2CBFCDE4733A @default.
- Q99560587 P1476 Q99560587-6D6570D1-1438-4E46-AE56-136A7BE3D2F6 @default.
- Q99560587 P2093 Q99560587-2EB6DEB1-2C35-47C4-B541-C8A594D2DFA9 @default.
- Q99560587 P2093 Q99560587-6E5F1449-D143-470F-8F4B-F1E4E33B5809 @default.
- Q99560587 P2093 Q99560587-C8003FB3-4C53-474B-B712-ED5F90163CCC @default.
- Q99560587 P2093 Q99560587-CFB17783-69FC-4398-8DAA-2887A28CDB71 @default.
- Q99560587 P2093 Q99560587-DB34C28F-C08D-4BE4-B180-77D2ACCE5C90 @default.
- Q99560587 P2093 Q99560587-DE68560D-D92B-4C13-93AE-F5CA24FD8D79 @default.
- Q99560587 P2093 Q99560587-FD2C5E70-793D-45C2-8C2E-C4FD25156F40 @default.
- Q99560587 P31 Q99560587-193BB95A-C04B-48DC-B442-106875DB1003 @default.
- Q99560587 P356 Q99560587-7D0D082E-DA33-45E4-864F-E244D6BD04BD @default.
- Q99560587 P50 Q99560587-0DDF3AEA-E97E-41FC-B3E3-B2E49AF871DF @default.
- Q99560587 P577 Q99560587-F3016E93-3241-405E-89EE-41994C2B6F60 @default.
- Q99560587 P698 Q99560587-EDA19601-234E-45DB-9693-98AE5652153A @default.
- Q99560587 P356 KEAA463 @default.
- Q99560587 P698 32940703 @default.
- Q99560587 P1433 Q7320492 @default.
- Q99560587 P1476 "Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion" @default.
- Q99560587 P2093 "Andrea Doria" @default.
- Q99560587 P2093 "Francesca Saccon" @default.
- Q99560587 P2093 "Francesco Benvenuti" @default.
- Q99560587 P2093 "Luca Iaccarino" @default.
- Q99560587 P2093 "Maddalena Larosa" @default.
- Q99560587 P2093 "Mariele Gatto" @default.
- Q99560587 P2093 "Marta Loredo Martinez" @default.
- Q99560587 P31 Q13442814 @default.
- Q99560587 P356 "10.1093/RHEUMATOLOGY/KEAA463" @default.
- Q99560587 P50 Q114314230 @default.
- Q99560587 P577 "2020-09-17T00:00:00Z" @default.
- Q99560587 P698 "32940703" @default.